Insight Sciences

Did Glaxo Violate Its Corporate Integrity Agreement?
Ed Silverman, forbes.com

The ongo­ing bribery scan­dal that Glax­o­SmithK­line faces in China may have gen­er­at­ed sen­sa­tion­al head­lines, but its shares have most­ly trad­ed in the same nar­row range since these episode erupt­ed (back sto­ries here and here). Althoug…

http://flip.it/NyQgb